A 12-Gene Blood-Based Signature for Detecting Metastatic Bladder Cancer
NCT00918008
·
clinicaltrials.gov ↗
TERMINATED
Status
12
Enrollment
OTHER
Sponsor class
Stopped
Lack of accrual
Conditions
Bladder Cancer
Interventions
GENETIC:
Blood draw
Sponsor
Memorial Sloan Kettering Cancer Center
Collaborators
[object Object]
[object Object]